Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, et al.
World Journal of Virology (2022) Vol. 11, Iss. 5, pp. 221-236
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 20
A respiratory mucosal vaccine based on chitosan/aluminum adjuvant induces both mucosal and systemic immune responses
Ruitong Chen, Meifeng Nie, Yili Jiang, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125168-125168
Closed Access | Times Cited: 1
Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery
Chiara Gai, Margherita Alba Carlotta Pomatto, Maria Chiara Deregibus, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 200-200
Open Access | Times Cited: 8
Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
Junwei Gao, Can Cao, Mingfei Shi, et al.
Phytomedicine (2023) Vol. 118, pp. 154942-154942
Open Access | Times Cited: 17
Tomato-made edible COVID-19 vaccine TOMAVAC induces neutralizing IgGs in the blood sera of mice and humans
Zabardast T. Buriev, Shukhrat E. Shermatov, Dilshod E. Usmanov, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 5
Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery
Chiara Gai, Margherita Alba Carlotta Pomatto, Maria Chiara Deregibus, et al.
(2024)
Open Access | Times Cited: 5
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Oral Immunisation With Non‐GMO Surface Displayed SARS‐CoV‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice
Robie Vasquez, Ji Hoon Song, Remilyn M. Mendoza, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Microneedle-delivered adeno-associated virus vaccine amplified anti-viral immunity by improving antigen-presenting cells infection
Penghui He, Chun‐Ting He, Fuhua Wu, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 1045-1057
Closed Access
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization
Salvatore Calogero Gaglio, Massimiliano Perduca, Donato Zipeto, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1333-1333
Open Access | Times Cited: 10
Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19
Jean‐Marc Cavaillon, Benjamin G. Chousterman, Tomasz Skirecki
Journal of Intensive Medicine (2024) Vol. 4, Iss. 3, pp. 326-340
Open Access | Times Cited: 3
Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity
Mila Biswas, Md Nurunnabi, Zehedina Khatun
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 5037-5056
Closed Access | Times Cited: 3
Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 spike epitopes in mice
In‐Chan Hwang, Robie Vasquez, Ji Hoon Song, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity
Ileana García-Silva, Dania O. Govea‐Alonso, Sergio Rosales‐Mendoza
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 2, pp. 207-222
Closed Access | Times Cited: 5
Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants
Nur Farhanah Arshad, Fariza Juliana Nordin, Lian Chee Foong, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306111-e0306111
Open Access | Times Cited: 1
High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters
Martin J. Lett, Fabian Otte, David Hauser, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
The edible tomato COVID-19 vaccine, TOMAVAC, induces neutralising IgGs
Ibrokhim Y. Abdurakhmonov, Zabardast T. Buriev, Shukhrat E. Shermatov, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Live attenuated COVID-19 vaccines: approaches to development and prospects for clinical use
E. R. Korchevaya, A. V. Gracheva, I. N. Dyakov, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 3, pp. 225-236
Open Access | Times Cited: 2
SARS-CoV-2 Variant-Specific Gastrointestinal Symptoms of COVID-19: 2023 Update
Yoanna Slabakova, Stavros Gerasoudis, Dimitrina Miteva, et al.
Gastroenterology Insights (2023) Vol. 14, Iss. 4, pp. 431-445
Open Access | Times Cited: 2
Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination
Brittany A. Comunale, Robin J. Larson, Yea‐Jen Hsu, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 219-219
Open Access
Effects of post-COVID-19 vaccination in oral cavity: a systematic review
Anubhuti Sood, Sreevatsan Raghavan, Deepika Mishra, et al.
Evidence-Based Dentistry (2024) Vol. 25, Iss. 3, pp. 168-168
Closed Access
mRNA Technology and Mucosal Immunization
Antonio Toniolo, Giuseppe Maccari, Giovanni Camussi
Vaccines (2024) Vol. 12, Iss. 6, pp. 670-670
Open Access
Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Journal of microbiology epidemiology immunobiology (2024) Vol. 101, Iss. 1, pp. 36-51
Open Access
Intranasal and Inhaled Vaccines
Michael Y.T. Chow, Jenny K.W. Lam
AAPS introductions in the pharmaceutical sciences (2023), pp. 123-148
Closed Access | Times Cited: 1
Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron VOCs
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top